#Argenx #CHMP #CIDPtreatment #VYVGART #efgartigimodalfa #chronicinflammatorydemyelinatingpolyneuropathy #CIDPdrug #ADHEREtrial #CIDPclinicalstudy #IgGFcantibodyfragment #immunoglobulintherapy #CIPDpatients #EPODIN #CIPDmanagement #CHMPrecommendation #CHMPopinion
pharmatimes.com/news/argenx-...
pharmatimes.com/news/argenx-...
Argenx receives positive CHMP opinion for CIDP treatment - PharmaTimes
VYVGART could be the first CIDP drug with a novel mechanism in 30 years
pharmatimes.com
May 6, 2025 at 8:40 AM